ABX Plus Cisplatin Versus Gemcitabine Plus Cisplatin in Triple Negative Breast Cancer (TNBC) (TNBC)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02546934 |
Recruitment Status :
Completed
First Posted : September 11, 2015
Last Update Posted : April 22, 2022
|
Sponsor:
Fudan University
Information provided by (Responsible Party):
Xichun Hu, Fudan University
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Completed |
---|---|
Actual Primary Completion Date : | April 2020 |
Actual Study Completion Date : | April 2020 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):